Crinetics Pharmaceuticals Inc (CRNX)

56.82 +0.13 (+0.23%) USD  |  NASDAQ  |  Nov 04, 16:00
58.94 +2.12 (+3.73%) After-Hours: 06:24
More

Crinetics Pharmaceuticals Asset Impairment Charge (Quarterly)

Asset Impairment Charge (Quarterly) Chart

View Asset Impairment Charge (Quarterly) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Asset Impairment Charge (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Asset Impairment Charge Definition

Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.

Read full definition.

Asset Impairment Charge (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Asset Impairment Charge (Quarterly) Benchmarks

PTC Therapeutics Inc Upgrade
Zevra Therapeutics Inc --
Clearside Biomedical Inc --
Biomea Fusion Inc --
NovaBay Pharmaceuticals Inc --